SHANGHAI, Nov. 14, 2016 /PRNewswire/ -- Long Hill Capital Management (LHC), a China-focused venture capital firm, today announced that it has closed Long Hill Capital Venture Partners 1, a $125M fund to invest in early stage technology-enabled healthcare and consumer services companies based in China. Long Hill Capital's inaugural fund was raised in October, less than 6 months from initial launch, during a much talked about "winter" for China's venture capital industry. Long Hill Capital Venture Partners 1 will be managed by Xiaodong Jiang and Bo Jiang who since 2005 have led the China investing practice for New Enterprise Associates (NEA), a global investment firm with over $17 billion in committed capital. They are joined by an experienced team of investment and operations professionals from such firms as Matrix Partners China and Morningside VC. Together the Long Hill Capital team have over 30 years of China venture capital experience and over 15 years of senior operating experience at some of China's most successful technology and healthcare companies including Alibaba, Huawei and Ping'an Good Doctor. Over the course of their venture capital careers, the Long Hill Capital team have invested in such industry leading companies as CITIC Pharmaceutical, WeDoctor, Hygeia Medical Services, GST Clinics, LineKong, LianLian Pay, Ele.Me, TheBeastShop and more. " China will have both more middle class consumers and more senior citizens over age 60 than the entire population of the United States in the next decade," said Xiaodong Jiang, Managing Partner of Long Hill Capital. "The Chinese healthcare and consumer services industries are embracing technology in an unprecedented way. We cannot be more excited to build upon our track record of success and continue to invest in next generation entrepreneurs who seek to massively improve health and quality of life for every Chinese."